DK0489181T3 - Fast præparat - Google Patents

Fast præparat

Info

Publication number
DK0489181T3
DK0489181T3 DK91913065.8T DK91913065T DK0489181T3 DK 0489181 T3 DK0489181 T3 DK 0489181T3 DK 91913065 T DK91913065 T DK 91913065T DK 0489181 T3 DK0489181 T3 DK 0489181T3
Authority
DK
Denmark
Prior art keywords
solid preparation
preparation
solid
Prior art date
Application number
DK91913065.8T
Other languages
Danish (da)
English (en)
Inventor
Toru Nishibayashi
Yoshihiro Ishizue
Kozo Ishida
Masanori Kubo
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK0489181T3 publication Critical patent/DK0489181T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91913065.8T 1990-07-19 1991-07-17 Fast præparat DK0489181T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19211290 1990-07-19

Publications (1)

Publication Number Publication Date
DK0489181T3 true DK0489181T3 (da) 1996-11-18

Family

ID=16285866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913065.8T DK0489181T3 (da) 1990-07-19 1991-07-17 Fast præparat

Country Status (9)

Country Link
US (1) US5316773A (enExample)
EP (1) EP0489181B1 (enExample)
JP (1) JPH07112975B2 (enExample)
KR (1) KR0172134B1 (enExample)
AU (1) AU641267B2 (enExample)
DE (1) DE69122478T2 (enExample)
DK (1) DK0489181T3 (enExample)
ES (1) ES2093106T3 (enExample)
WO (1) WO1992001453A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047495A1 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
WO2003000226A2 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
DE10351644A1 (de) 2003-11-05 2005-06-09 Bayer Technology Services Gmbh Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen
AR065720A1 (es) * 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
BR112015027611A2 (pt) 2013-01-28 2022-03-03 Univ Kansas State Molécula de ácido nucleico isolada; célula hospedeira; vetor; proteína ou polipeptídeo isolado; imunorreagente específico de vírus da febre do vale do rift (rvfv); uso de uma composição; uso de uma composição para o diagnóstico de febre do vale do rift (rvf) em um indivíduo; e kit

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430684A (en) * 1972-06-26 1976-03-31 Lowey H Prolonged release lozenges
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS5899411A (ja) * 1981-12-05 1983-06-13 Shoichiro Ozaki 制ガン剤
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DK169520B1 (da) * 1986-07-25 1994-11-21 Otsuka Pharma Co Ltd 5-fluoruracilderivater, fremgangsmåde til deres fremstilling, anticancerpræparat indeholdende et sådant derivat og anvendelse af et sådant derivat til fremstilling af et præparat til behandling af cancer
JPS63201127A (ja) * 1987-02-17 1988-08-19 Otsuka Pharmaceut Co Ltd 5−フルオロウラシル誘導体を含有する制癌剤
JPS63115817A (ja) * 1986-11-04 1988-05-20 Mitsubishi Kasei Corp 肝疾患治療薬組成物
ES2043766T3 (es) * 1987-11-11 1994-01-01 Pharmascience Lab Una nueva composicion farmaceutica que comprende exifona y un polimero soluble en agua.
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
NL194430C (nl) * 1989-01-05 2002-04-04 Otsuka Pharma Co Ltd Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament

Also Published As

Publication number Publication date
ES2093106T3 (es) 1996-12-16
US5316773A (en) 1994-05-31
EP0489181A1 (en) 1992-06-10
JPH07112975B1 (enExample) 1995-12-06
EP0489181B1 (en) 1996-10-02
KR920702221A (ko) 1992-09-03
DE69122478D1 (de) 1996-11-07
AU8219091A (en) 1992-02-18
WO1992001453A1 (fr) 1992-02-06
KR0172134B1 (ko) 1999-02-01
EP0489181A4 (en) 1992-09-30
DE69122478T2 (de) 1997-05-28
JPH07112975B2 (ja) 1995-12-06
AU641267B2 (en) 1993-09-16

Similar Documents

Publication Publication Date Title
FI925852L (fi) Aerosolkompositioner under tryck
ATA150090A (de) Hoergeraet
FI930058L (fi) O-glykolyserad alfa-ifn
FI930894A0 (fi) Form foer flotationsprodukter
ATA210290A (de) Lotpille
BR9101214A (pt) Ministrador
DK0489181T3 (da) Fast præparat
ATA80690A (de) Alpinschi
ATA200090A (de) Pianino
ATA237490A (de) Rinnenstein
ATA209290A (de) Diaraehmchen
BR9101437A (pt) Copoliester
BR9003611A (pt) Hidrobaliador
BR9002505A (pt) Venturbo
SE9003187D0 (sv) Laettoemd faagelholk
BR7002637U (pt) Coperculo
BR7001930U (pt) Terrario
BR9003946A (pt) Higi-protec
BR9003873A (pt) Quadriciclo
BR9004090A (pt) Coperculo defenciado
BR9004869A (pt) Cortina-boxe
BR7002895U (pt) Embalagem-mostruario
BR7002759U (pt) Multiroaster
BR7002736U (pt) Descansa-pes
BR9005705A (pt) Berco sanfonado